| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615228 | Journal of Clinical Lipidology | 2017 | 10 Pages |
Abstract
Healthcare providers encounter significant barriers to PCSK9 inhibitor prescriptions; many of these are related to documentation issues and can be overcome with checklists, staff support, and experience.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jerome D. MD, Mark J. PharmD, Terry A. MD, Kevin C. PhD, Dean G. MD,